rs397515558
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP4_StrongPM6PP3PM2_SupportingPS4_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_005629.4:c.1631C>T in SLC6A8 is a missense variant predicted to cause substitution of Proline with Leucine (p.Pro544Leu) at amino acid 544 in the 12th of 13 exons. This variant is absent from gnomAD v2.1.1, (PM2_Supporting). The computational predictor REVEL gives a score of 0.784 which is above the threshold of 0.75, evidence that correlates with impact to SLC6A8 function (PP3). This variant was reported in a 5 year-old boy with known speech delay who presented with severe and refractory epilepsy. Urine analysis showed an increased creatine/creatinine ratio (1.83; n.v. 0.03–0.92) with normal guanidinoacetate/creatinine ratio (0.024; n.v. 0.023–0.214) (1 point). Brain MRI with angiography and perfusion study was normal, while 1H-MRS revealed a consistent decrease in the creatine peak (Fig. 2) (3 points). Full sequencing of the SLC6A8 gene was reported. (PMID:17553121) (PP4_Strong). This variant was reported in a proband with an increased urine creatine/creatinine ratio of 2.0 (normal range 0.017–0.72), the proband’s brother also was affected and had elevated urine ratios and was hemizygous for the variant, while their mother was heterozygous for the same variant (PMID:15690373). (PS4_Supporting). A female proband presented with learning disabilities, seizures and significantly reduced creatine by 1 H-MRS (fig. 1). The patient had normal urine creatine/creatinine ratio (0.38 mmol/mmol). Molecular genetic testing identified the heterozygous variant SLC6A8 (c.1631C>T, p.(Pro544Leu)). Segregation analysis including both parents revealed that the variant was de novo in the patient (PMID:37708665) (PM6). This variant was assessed for co-segregation evidence (PP1) and functional evidence (PS3), but in both cases did not meet the specifications (PP1_Not Met, PS3_Not Met). In summary, this variant meets the criteria to be classified as a Likely Pathogenic variant for Creatine Transporter Deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 1.1.0). PM2_Supporting, PP3, PP4_Strong, PS4_Supporting, PM6.(Classification approved by the ClinGen CCDS VCEP on Oct. 26, 2023) LINK:https://erepo.genome.network/evrepo/ui/classification/CA345034/MONDO:0010305/027
Frequency
Consequence
NM_005629.4 missense
Scores
Clinical Significance
Conservation
Publications
- creatine transporter deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005629.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | MANE Select | c.1631C>T | p.Pro544Leu | missense | Exon 12 of 13 | NP_005620.1 | P48029-1 | ||
| SLC6A8 | c.1601C>T | p.Pro534Leu | missense | Exon 12 of 13 | NP_001136277.1 | ||||
| SLC6A8 | c.1286C>T | p.Pro429Leu | missense | Exon 12 of 13 | NP_001136278.1 | P48029-4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | TSL:1 MANE Select | c.1631C>T | p.Pro544Leu | missense | Exon 12 of 13 | ENSP00000253122.5 | P48029-1 | ||
| SLC6A8 | c.1628C>T | p.Pro543Leu | missense | Exon 12 of 13 | ENSP00000625834.1 | ||||
| SLC6A8 | c.1622C>T | p.Pro541Leu | missense | Exon 12 of 13 | ENSP00000592689.1 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 38
GnomAD4 genome Cov.: 25
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at